Outcomes of cataract surgery in diabetic patients: results of the Pan American Collaborative Retina Study Group
This study was designed to evaluate the visual and anatomical outcomes after cataract surgery in diabetic patients with different intraoperative therapeutic strategies. The research design comprised of a multicentric, retrospective, interventional study conducted at 6 centers in Argentina, Brazil, C...
Gespeichert in:
| Veröffentlicht in: | Arquivos brasileiros de oftalmologia 2014-11, Vol.77 (6), p.355-359 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 359 |
|---|---|
| container_issue | 6 |
| container_start_page | 355 |
| container_title | Arquivos brasileiros de oftalmologia |
| container_volume | 77 |
| creator | Gallego-Pinazo, Roberto Dolz-Marco, Rosa Berrocal, Maria Wu, Lihteh Maia, Mauricio Serrano, Martín Alezzandrini, Arturo Arévalo, J Fernando Díaz-Llopis, Manuel |
| description | This study was designed to evaluate the visual and anatomical outcomes after cataract surgery in diabetic patients with different intraoperative therapeutic strategies.
The research design comprised of a multicentric, retrospective, interventional study conducted at 6 centers in Argentina, Brazil, Costa Rica, Puerto Rico, Spain, and Venezuela. We included 138 diabetic patients with at least 6-month follow-up following phacoemulsification and intraocular lens implantation. Best-corrected visual acuity (BCVA) and central subfield thickness were collected at baseline and at 1-, 2-, 3-, and 6-month follow-up. Of these, 42 cases were not treated with any intraoperative coadjuvant medication (Group 1), 59 patients received intraoperative bevacizumab (Group 2) and 37 patients received intraoperative triamcinolone (4 mg/0.1 ml) (Group 3).
The mean logMAR [± standard deviation (SD)] BCVA improved from 0.82 (± 0.43) at baseline, to 0.14 (± 0.23) at 6-month follow-up (p |
| doi_str_mv | 10.5935/0004-2749.20140089 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_sciel</sourceid><recordid>TN_cdi_scielo_journals_S0004_27492014000600008</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><scielo_id>S0004_27492014000600008</scielo_id><sourcerecordid>1652441085</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-515dd91cd6006698c294366818e724afa138cf305e8100dda6aac8625d9565493</originalsourceid><addsrcrecordid>eNo9kU9vEzEQxS0EoqHwBTggH7lsGHttx-ZWRVAqVSqicLYcexa22l0H_6mUb49D2pxmDu83T_MeIe8ZrKXp5ScAEB3fCLPmwASANi_IiqmN7rjh8iVZnQUX5E3ODwBcGCNfkwsuFd8wDSsS72rxccZM40C9Ky45X2iu6TemAx0XGka3wzJ6undlxKXkzzRhrlP5T5Q_SL-7hV7NmEbflm2cJreLqYkfkf5o5OLofanhQK9TrPu35NXgpozvnuYl-fX1y8_tt-727vpme3Xb-V6r0kkmQzDMBwWglNGeG9ErpZnGDRducKzXfuhBomYAITjlnNeKy2CkksL0l2R9upv9iFO0D7GmpRna-2Mo9hjKKTRoDi26Bnw8AfsU_1bMxc5j9ti-WTDWbJmSXAgGWjYpP0l9ijknHOw-jbNLB8vAHpuxZw_73EyDPjzdr7sZwxl5rqL_B173hg4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1652441085</pqid></control><display><type>article</type><title>Outcomes of cataract surgery in diabetic patients: results of the Pan American Collaborative Retina Study Group</title><source>MEDLINE</source><source>IngentaConnect Free/Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Gallego-Pinazo, Roberto ; Dolz-Marco, Rosa ; Berrocal, Maria ; Wu, Lihteh ; Maia, Mauricio ; Serrano, Martín ; Alezzandrini, Arturo ; Arévalo, J Fernando ; Díaz-Llopis, Manuel</creator><creatorcontrib>Gallego-Pinazo, Roberto ; Dolz-Marco, Rosa ; Berrocal, Maria ; Wu, Lihteh ; Maia, Mauricio ; Serrano, Martín ; Alezzandrini, Arturo ; Arévalo, J Fernando ; Díaz-Llopis, Manuel ; Pan-American Collaborative Retina Study Group (PACORES)</creatorcontrib><description>This study was designed to evaluate the visual and anatomical outcomes after cataract surgery in diabetic patients with different intraoperative therapeutic strategies.
The research design comprised of a multicentric, retrospective, interventional study conducted at 6 centers in Argentina, Brazil, Costa Rica, Puerto Rico, Spain, and Venezuela. We included 138 diabetic patients with at least 6-month follow-up following phacoemulsification and intraocular lens implantation. Best-corrected visual acuity (BCVA) and central subfield thickness were collected at baseline and at 1-, 2-, 3-, and 6-month follow-up. Of these, 42 cases were not treated with any intraoperative coadjuvant medication (Group 1), 59 patients received intraoperative bevacizumab (Group 2) and 37 patients received intraoperative triamcinolone (4 mg/0.1 ml) (Group 3).
The mean logMAR [± standard deviation (SD)] BCVA improved from 0.82 (± 0.43) at baseline, to 0.14 (± 0.23) at 6-month follow-up (p<0.001) in Group 1; from 0.80 (± 0.48) to 0.54 (± 0.45) (p<0.001) in Group 2; and from 1.0 (± 0.40) to 0.46 (± 0.34) (p<0.001) in Group 3. The mean central subfield thickness increased from 263.57 µm (± 35.7) at baseline to 274.57 µm (± 48.7) at 6-month follow-up (p=0.088) in Group 1; from 316.02 µm (± 100.4) to 339.56 µm (± 145.3) (p=0.184) in Group 2; and from 259.18 µm (± 97.9) to 282.21 µm (± 87.24) (p=0.044) in Group 3.
Diabetic patients may significantly benefit from cataract surgery. This study provides evidence to support the use of intravitreal triamcinolone or bevacizumab at the time of cataract surgery in cases with pre-existent diabetic macular edema or moderate-severe non-proliferative diabetic retinopathy.</description><identifier>ISSN: 0004-2749</identifier><identifier>ISSN: 1678-2925</identifier><identifier>EISSN: 1678-2925</identifier><identifier>DOI: 10.5935/0004-2749.20140089</identifier><identifier>PMID: 25627180</identifier><language>eng</language><publisher>Brazil: Conselho Brasileiro de Oftalmologia</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Angiogenesis Inhibitors - therapeutic use ; Antibodies, Monoclonal, Humanized - therapeutic use ; Bevacizumab ; Cataract - drug therapy ; Chemotherapy, Adjuvant - methods ; Diabetic Retinopathy - surgery ; Female ; Follow-Up Studies ; Glucocorticoids - therapeutic use ; Humans ; Intraoperative Care ; Intravitreal Injections ; Lens Implantation, Intraocular - methods ; Macular Edema - drug therapy ; Male ; Middle Aged ; OPHTHALMOLOGY ; Phacoemulsification - methods ; Retrospective Studies ; Treatment Outcome ; Triamcinolone - therapeutic use ; Vascular Endothelial Growth Factor A - antagonists & inhibitors ; Visual Acuity</subject><ispartof>Arquivos brasileiros de oftalmologia, 2014-11, Vol.77 (6), p.355-359</ispartof><rights>This work is licensed under a Creative Commons Attribution 4.0 International License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-515dd91cd6006698c294366818e724afa138cf305e8100dda6aac8625d9565493</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25627180$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gallego-Pinazo, Roberto</creatorcontrib><creatorcontrib>Dolz-Marco, Rosa</creatorcontrib><creatorcontrib>Berrocal, Maria</creatorcontrib><creatorcontrib>Wu, Lihteh</creatorcontrib><creatorcontrib>Maia, Mauricio</creatorcontrib><creatorcontrib>Serrano, Martín</creatorcontrib><creatorcontrib>Alezzandrini, Arturo</creatorcontrib><creatorcontrib>Arévalo, J Fernando</creatorcontrib><creatorcontrib>Díaz-Llopis, Manuel</creatorcontrib><creatorcontrib>Pan-American Collaborative Retina Study Group (PACORES)</creatorcontrib><title>Outcomes of cataract surgery in diabetic patients: results of the Pan American Collaborative Retina Study Group</title><title>Arquivos brasileiros de oftalmologia</title><addtitle>Arq Bras Oftalmol</addtitle><description>This study was designed to evaluate the visual and anatomical outcomes after cataract surgery in diabetic patients with different intraoperative therapeutic strategies.
The research design comprised of a multicentric, retrospective, interventional study conducted at 6 centers in Argentina, Brazil, Costa Rica, Puerto Rico, Spain, and Venezuela. We included 138 diabetic patients with at least 6-month follow-up following phacoemulsification and intraocular lens implantation. Best-corrected visual acuity (BCVA) and central subfield thickness were collected at baseline and at 1-, 2-, 3-, and 6-month follow-up. Of these, 42 cases were not treated with any intraoperative coadjuvant medication (Group 1), 59 patients received intraoperative bevacizumab (Group 2) and 37 patients received intraoperative triamcinolone (4 mg/0.1 ml) (Group 3).
The mean logMAR [± standard deviation (SD)] BCVA improved from 0.82 (± 0.43) at baseline, to 0.14 (± 0.23) at 6-month follow-up (p<0.001) in Group 1; from 0.80 (± 0.48) to 0.54 (± 0.45) (p<0.001) in Group 2; and from 1.0 (± 0.40) to 0.46 (± 0.34) (p<0.001) in Group 3. The mean central subfield thickness increased from 263.57 µm (± 35.7) at baseline to 274.57 µm (± 48.7) at 6-month follow-up (p=0.088) in Group 1; from 316.02 µm (± 100.4) to 339.56 µm (± 145.3) (p=0.184) in Group 2; and from 259.18 µm (± 97.9) to 282.21 µm (± 87.24) (p=0.044) in Group 3.
Diabetic patients may significantly benefit from cataract surgery. This study provides evidence to support the use of intravitreal triamcinolone or bevacizumab at the time of cataract surgery in cases with pre-existent diabetic macular edema or moderate-severe non-proliferative diabetic retinopathy.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Angiogenesis Inhibitors - therapeutic use</subject><subject>Antibodies, Monoclonal, Humanized - therapeutic use</subject><subject>Bevacizumab</subject><subject>Cataract - drug therapy</subject><subject>Chemotherapy, Adjuvant - methods</subject><subject>Diabetic Retinopathy - surgery</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Glucocorticoids - therapeutic use</subject><subject>Humans</subject><subject>Intraoperative Care</subject><subject>Intravitreal Injections</subject><subject>Lens Implantation, Intraocular - methods</subject><subject>Macular Edema - drug therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>OPHTHALMOLOGY</subject><subject>Phacoemulsification - methods</subject><subject>Retrospective Studies</subject><subject>Treatment Outcome</subject><subject>Triamcinolone - therapeutic use</subject><subject>Vascular Endothelial Growth Factor A - antagonists & inhibitors</subject><subject>Visual Acuity</subject><issn>0004-2749</issn><issn>1678-2925</issn><issn>1678-2925</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kU9vEzEQxS0EoqHwBTggH7lsGHttx-ZWRVAqVSqicLYcexa22l0H_6mUb49D2pxmDu83T_MeIe8ZrKXp5ScAEB3fCLPmwASANi_IiqmN7rjh8iVZnQUX5E3ODwBcGCNfkwsuFd8wDSsS72rxccZM40C9Ky45X2iu6TemAx0XGka3wzJ6undlxKXkzzRhrlP5T5Q_SL-7hV7NmEbflm2cJreLqYkfkf5o5OLofanhQK9TrPu35NXgpozvnuYl-fX1y8_tt-727vpme3Xb-V6r0kkmQzDMBwWglNGeG9ErpZnGDRducKzXfuhBomYAITjlnNeKy2CkksL0l2R9upv9iFO0D7GmpRna-2Mo9hjKKTRoDi26Bnw8AfsU_1bMxc5j9ti-WTDWbJmSXAgGWjYpP0l9ijknHOw-jbNLB8vAHpuxZw_73EyDPjzdr7sZwxl5rqL_B173hg4</recordid><startdate>20141101</startdate><enddate>20141101</enddate><creator>Gallego-Pinazo, Roberto</creator><creator>Dolz-Marco, Rosa</creator><creator>Berrocal, Maria</creator><creator>Wu, Lihteh</creator><creator>Maia, Mauricio</creator><creator>Serrano, Martín</creator><creator>Alezzandrini, Arturo</creator><creator>Arévalo, J Fernando</creator><creator>Díaz-Llopis, Manuel</creator><general>Conselho Brasileiro de Oftalmologia</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>GPN</scope></search><sort><creationdate>20141101</creationdate><title>Outcomes of cataract surgery in diabetic patients: results of the Pan American Collaborative Retina Study Group</title><author>Gallego-Pinazo, Roberto ; Dolz-Marco, Rosa ; Berrocal, Maria ; Wu, Lihteh ; Maia, Mauricio ; Serrano, Martín ; Alezzandrini, Arturo ; Arévalo, J Fernando ; Díaz-Llopis, Manuel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-515dd91cd6006698c294366818e724afa138cf305e8100dda6aac8625d9565493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Angiogenesis Inhibitors - therapeutic use</topic><topic>Antibodies, Monoclonal, Humanized - therapeutic use</topic><topic>Bevacizumab</topic><topic>Cataract - drug therapy</topic><topic>Chemotherapy, Adjuvant - methods</topic><topic>Diabetic Retinopathy - surgery</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Glucocorticoids - therapeutic use</topic><topic>Humans</topic><topic>Intraoperative Care</topic><topic>Intravitreal Injections</topic><topic>Lens Implantation, Intraocular - methods</topic><topic>Macular Edema - drug therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>OPHTHALMOLOGY</topic><topic>Phacoemulsification - methods</topic><topic>Retrospective Studies</topic><topic>Treatment Outcome</topic><topic>Triamcinolone - therapeutic use</topic><topic>Vascular Endothelial Growth Factor A - antagonists & inhibitors</topic><topic>Visual Acuity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gallego-Pinazo, Roberto</creatorcontrib><creatorcontrib>Dolz-Marco, Rosa</creatorcontrib><creatorcontrib>Berrocal, Maria</creatorcontrib><creatorcontrib>Wu, Lihteh</creatorcontrib><creatorcontrib>Maia, Mauricio</creatorcontrib><creatorcontrib>Serrano, Martín</creatorcontrib><creatorcontrib>Alezzandrini, Arturo</creatorcontrib><creatorcontrib>Arévalo, J Fernando</creatorcontrib><creatorcontrib>Díaz-Llopis, Manuel</creatorcontrib><creatorcontrib>Pan-American Collaborative Retina Study Group (PACORES)</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>SciELO</collection><jtitle>Arquivos brasileiros de oftalmologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gallego-Pinazo, Roberto</au><au>Dolz-Marco, Rosa</au><au>Berrocal, Maria</au><au>Wu, Lihteh</au><au>Maia, Mauricio</au><au>Serrano, Martín</au><au>Alezzandrini, Arturo</au><au>Arévalo, J Fernando</au><au>Díaz-Llopis, Manuel</au><aucorp>Pan-American Collaborative Retina Study Group (PACORES)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcomes of cataract surgery in diabetic patients: results of the Pan American Collaborative Retina Study Group</atitle><jtitle>Arquivos brasileiros de oftalmologia</jtitle><addtitle>Arq Bras Oftalmol</addtitle><date>2014-11-01</date><risdate>2014</risdate><volume>77</volume><issue>6</issue><spage>355</spage><epage>359</epage><pages>355-359</pages><issn>0004-2749</issn><issn>1678-2925</issn><eissn>1678-2925</eissn><abstract>This study was designed to evaluate the visual and anatomical outcomes after cataract surgery in diabetic patients with different intraoperative therapeutic strategies.
The research design comprised of a multicentric, retrospective, interventional study conducted at 6 centers in Argentina, Brazil, Costa Rica, Puerto Rico, Spain, and Venezuela. We included 138 diabetic patients with at least 6-month follow-up following phacoemulsification and intraocular lens implantation. Best-corrected visual acuity (BCVA) and central subfield thickness were collected at baseline and at 1-, 2-, 3-, and 6-month follow-up. Of these, 42 cases were not treated with any intraoperative coadjuvant medication (Group 1), 59 patients received intraoperative bevacizumab (Group 2) and 37 patients received intraoperative triamcinolone (4 mg/0.1 ml) (Group 3).
The mean logMAR [± standard deviation (SD)] BCVA improved from 0.82 (± 0.43) at baseline, to 0.14 (± 0.23) at 6-month follow-up (p<0.001) in Group 1; from 0.80 (± 0.48) to 0.54 (± 0.45) (p<0.001) in Group 2; and from 1.0 (± 0.40) to 0.46 (± 0.34) (p<0.001) in Group 3. The mean central subfield thickness increased from 263.57 µm (± 35.7) at baseline to 274.57 µm (± 48.7) at 6-month follow-up (p=0.088) in Group 1; from 316.02 µm (± 100.4) to 339.56 µm (± 145.3) (p=0.184) in Group 2; and from 259.18 µm (± 97.9) to 282.21 µm (± 87.24) (p=0.044) in Group 3.
Diabetic patients may significantly benefit from cataract surgery. This study provides evidence to support the use of intravitreal triamcinolone or bevacizumab at the time of cataract surgery in cases with pre-existent diabetic macular edema or moderate-severe non-proliferative diabetic retinopathy.</abstract><cop>Brazil</cop><pub>Conselho Brasileiro de Oftalmologia</pub><pmid>25627180</pmid><doi>10.5935/0004-2749.20140089</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0004-2749 |
| ispartof | Arquivos brasileiros de oftalmologia, 2014-11, Vol.77 (6), p.355-359 |
| issn | 0004-2749 1678-2925 1678-2925 |
| language | eng |
| recordid | cdi_scielo_journals_S0004_27492014000600008 |
| source | MEDLINE; IngentaConnect Free/Open Access Journals; EZB-FREE-00999 freely available EZB journals |
| subjects | Adult Aged Aged, 80 and over Angiogenesis Inhibitors - therapeutic use Antibodies, Monoclonal, Humanized - therapeutic use Bevacizumab Cataract - drug therapy Chemotherapy, Adjuvant - methods Diabetic Retinopathy - surgery Female Follow-Up Studies Glucocorticoids - therapeutic use Humans Intraoperative Care Intravitreal Injections Lens Implantation, Intraocular - methods Macular Edema - drug therapy Male Middle Aged OPHTHALMOLOGY Phacoemulsification - methods Retrospective Studies Treatment Outcome Triamcinolone - therapeutic use Vascular Endothelial Growth Factor A - antagonists & inhibitors Visual Acuity |
| title | Outcomes of cataract surgery in diabetic patients: results of the Pan American Collaborative Retina Study Group |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T04%3A52%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_sciel&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcomes%20of%20cataract%20surgery%20in%20diabetic%20patients:%20results%20of%20the%20Pan%20American%20Collaborative%20Retina%20Study%20Group&rft.jtitle=Arquivos%20brasileiros%20de%20oftalmologia&rft.au=Gallego-Pinazo,%20Roberto&rft.aucorp=Pan-American%20Collaborative%20Retina%20Study%20Group%20(PACORES)&rft.date=2014-11-01&rft.volume=77&rft.issue=6&rft.spage=355&rft.epage=359&rft.pages=355-359&rft.issn=0004-2749&rft.eissn=1678-2925&rft_id=info:doi/10.5935/0004-2749.20140089&rft_dat=%3Cproquest_sciel%3E1652441085%3C/proquest_sciel%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1652441085&rft_id=info:pmid/25627180&rft_scielo_id=S0004_27492014000600008&rfr_iscdi=true |